DEA Proposes Temporarily Banning O-Desmethyltramadol Due to Safety Concerns
/ 1 min read
Table of Contents
The Drug Enforcement Administration has announced its intent to temporarily place a substance called O-desmethyltramadol (O-DSMT) into Schedule I of the Controlled Substances Act. This is a notice of intent, meaning the final rule will be published later. The temporary ban would take effect upon publication and last for two years unless changed.
Why it matters: This action aims to close a loophole where individuals might bypass prescription requirements by using or manufacturing O-DSMT directly. By temporarily classifying it as a Schedule I substance, the DEA can immediately restrict its distribution and possession while it conducts a more thorough review of whether permanent scheduling is necessary.
Who it affects
- Individuals who manufacture, sell, or possess O-DSMT outside of approved research channels
This notice was issued by the Drug Enforcement Administration via the Federal Register; readers should consult the full document at regulations.gov under Docket Number DEA-1641 for complete details before relying on this summary.
Agency: Justice Department, Drug Enforcement Administration
Source: Federal Register — read the official document